argenx SE (EBR:ARGX)
496.00
+9.70 (1.99%)
May 9, 2025, 5:39 PM CET
argenx SE Revenue
argenx SE had revenue of $807.37M USD in the quarter ending March 31, 2025, with 95.72% growth. This brings the company's revenue in the last twelve months to $2.64B, up 82.13% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.
Revenue (ttm)
$2.64B
Revenue Growth
+82.13%
P/S Ratio
12.14
Revenue / Employee
$1.65M
Employees
1,599
Market Cap
29.69B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | 979.61M | 77.22% |
Dec 31, 2023 | 1.27B | 827.58M | 187.66% |
Dec 31, 2022 | 441.01M | -87.25M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.15B |
Financière de Tubize | 13.26K |
Fagron NV | 871.96M |
Ion Beam Applications | 498.16M |
Nyxoah | 4.52M |
Onward Medical | 1.74M |
Hyloris Pharmaceuticals | 9.76M |
Sequana Medical NV | 105.50K |
argenx SE News
- 11 hours ago - Argenx Q1 Earnings: Less Than Perfect Report Gets Punished - Seeking Alpha
- 23 hours ago - Argenx targets Vision 2030 with 50,000 patients and 10 labeled indications by 2025 - Seeking Alpha
- 23 hours ago - argenx SE (ARGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Argenx plunges after Q1 revenue miss - Seeking Alpha
- 1 day ago - Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble - Investor's Business Daily
- 1 day ago - Earnings Scheduled For May 8, 2025 - Benzinga
- 1 day ago - Argenx reports mixed Q1 results; reaffirms FY25 outlook - Seeking Alpha
- 1 day ago - argenx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire